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ABSTRACT 1 
 2 
Objectives 3 
Fenestrated endovascular aneurysm repair (FEVAR) exposes operators and patients 4 
to considerable amounts of radiation. Introduction of fusion of three-dimensional 5 
(3D) computed tomography (CT) with intraoperative fluoroscopy puts new focus on 6 
advanced imaging techniques in the operating environment and has been found to 7 
reduce radiation and facilitate faster repair. The aim of this study is to evaluate the 8 
radiation dose effect of introducing a team-based approach to complex aortic repair. 9 
 10 
Methods 11 
Procedural details for a cohort of 21 patients undergoing FEVAR after fusion-guided 12 
(Modern Group) imaging was introduced are compared with 21 patients treated in 13 
the immediate 12 months prior to implementation (Historic Group) at a centre with 14 
expertise in FEVAR. Non-parametric tests were used to compare procedure time 15 
(PT), air kerma, dose-area product (DAP), fluoroscopy time (FT), estimated blood loss 16 
(EBL) and pre- and post-operative estimated glomerular filtration rate (eGFR) 17 
between the groups. 18 
 19 
Results 20 
Change in operative approach resulted in a significant reduction in PT for the 21 
Modern group (median 285 mins; interquartile range 268-322) compared with the 22 
Historic group (450 mins; IQR 360-540 p=<0.001). There were reductions in skin dose 23 
for the Modern group (1.6 Gy; IQR 1.09-2.1) compared with the Historic group (4.4 24 
Gy; 3.2-7.05 p=<0.001), and DAP (Modern 159 Gy.cm2; IQR 123-226 vs 264.93 25 
Gy.cm2; 173.3-366.8 for Historic (p=0.006). Estimated blood loss was significantly 26 
reduced for Modern (350 mls; 250-580) compared with Historic (1000 mls; 420-2300 27 
p=0.009). There were no significant differences in FT, and pre- and post-operative 28 
eGFR between the two groups. Weight and height were distributed equally across 29 
both groups.  30 
 31 
 32 
Conclusions 33 
Implementation of a team-based approach to radiation reduction significantly 34 
reduces radiation dose. These findings suggest that the radiation safety awareness 35 
that accompanies the introduction of fusion imaging may improve the overall 36 
radiation safety profile of FEVAR for patients and providers. 37 
 38 
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What this paper adds: 1 
This paper investigates the implementation of a team-based approach to radiation 2 
safety in complex aneurysm repairs. The importance of a systematic approach to 3 
radiation safety and the procedure itself, with improvement in the safety-profile of 4 
FEVAR must not only rely on specific imaging modalities but also on a systematic and 5 
integrated approach to all cases. 6 
 7 
 8 
9 
 4 
INTRODUCTION 1 
 2 
Imaging technology has evolved since the introduction of endovascular aneurysm 3 
repair (EVAR).1 Modern hybrid rooms have the capacity to combine pre-operative 4 
computed tomography (CT) with cone-beam computed tomography (CBCT) to assist 5 
intra-operative navigation and graft deployment (Fusion).2,3 Fusion usually employs 6 
rigid co-registration of consistent bony landmarks,4,5 but could employ orthogonal 7 
2D acquisitions6 and computational algorithms in real time.7 Fenestrated 8 
endovascular aneurysm repair (FEVAR) has increased the complexity of endovascular 9 
repair12,13, exposing the patient and surgeon to more radiation.8–10,11   10 
 11 
Existing data supports fusion imaging in complex aneurysm repair to reduce contrast 12 
volume and radiation dose.4–6,14   We believe the effect is augmented by an 13 
emphasis on dose reduction that introduction of a new technology can provide.  We 14 
review our experience with a new systematic and team-based approach to the 15 
routine use of advanced technologies like fusion, and hypothesize that this 16 
awareness is responsible for dose reduction.  17 
 18 
METHODS 19 
 20 
All patients who underwent complex endograft between January 2014 and May 21 
2015 were included in this before and after comparison study. This study documents 22 
a period of clinical change at our institution during which time Fusion Imaging 23 
techniques were introduced as standard of care, and there was a change in clinical 24 
leadership.  Guidance from HRA advised that this study did not fall under the remit 25 
 5 
of the NHS Research Ethics Committee, thus it is registered with the Royal Free NHS 1 
Foundation Trust as an audit in line with clinical guidelines.   2 
 3 
At our centre, all patients who are deemed clinically suitable for complex 4 
endovascular repair of aortic aneurysm undergo pre-operative high-resolution 5 
computed angiography (CTA) and selective pre-operative assessment including 6 
stress-echocardiography, pulmonary function testing, and CPEX testing, according to 7 
our care pathway.  Following multi-disciplinary team discussion, custom fenestrated 8 
or branched devices are designed and ordered.  9 
 10 
For this study, the Historic Group was a consecutive retrospective cohort of patients 11 
who received fenestrated grafts from January 2014 to October 2014, prior to the 12 
implementation of routine fusion imaging. These were identified from one surgeon’s 13 
personal log, and verified against data in the national vascular registry for our centre 14 
to ensure consecutive patients were captured. Patients were operated on by a 15 
senior experienced operator. Procedural data, including measures of radiation 16 
output, and short-term outcome data were gathered from the PACS system and 17 
from the patients’ medical records.  18 
 19 
After a change in clinical leadership, fusion imaging was implemented at our centre, 20 
and with it, a systematic approach to radiation safety that involved surgeons, nurses 21 
and radiographers.  Consecutive patients who received fenestrated stent grafts after 22 
fusion was introduced were included in the Modern Group. For these patients, 23 
procedural and perioperative data was collected by the investigators [AER, SR, MD, 24 
 6 
MD] as part of routine clinical auditing practice.  Reporting of consecutive cases was 1 
ensured by comparing against the national vascular registry. 2 
 3 
Fusion Protocol and Fluoroscopic Settings 4 
All patients were treated in the same hybrid suite, using the same fixed imaging 5 
equipment (Siemens Artis Zeego, Siemens Healthcare, Erlangen, Germany). All 6 
procedures were performed by an experienced surgeon, following ALARA principles, 7 
with a radiographer present in every case. In all cases, the senior surgeon/radiologist 8 
was operating the radiation pedal. 9 
 10 
In the Modern cohort, prior to the procedure, the surgical team imported the pre-11 
operative CTA onto the workstation and marked the target vessels using SyngoTM 12 
(Siemens Healthcare, Erlangen, Germany) software (fig.1a). All fluoroscopy used 13 
standardized low-dose settings of 32 nGy per pulse (which was changed to 18 nGy as 14 
of March 2015 in an effort to continually refine the technique and decrease dose), at 15 
3 pulses per second, unless modified at the surgeon’s discretion based on 16 
intraoperative judgement. The patients were fully prepared and draped to prevent 17 
patient movement after registration has been performed, and an additional 18 
temporary drape covered the entire operative field prior to rotational CBCT in order 19 
to maintain sterility. All staff retreated to a shielded area prior to CBCT. A 5sDR (5 20 
seconds, 133 frames at 30 f/s) was used (fig. 1b). The bony landmarks of the pre-21 
operative CTA were fused to the CBCT (fig. 1c). The rings identifying the target 22 
vessels were superimposed on the fluoroscopy screen and were not adjusted after 23 
index registration (fig. 1d). One surgeon with experience using the system provided 24 
 7 
technical support to radiographers.  During the procedure, senior level radiographers 1 
worked with the surgeon to ensure tight collimation, filtering and lowest-possible 2 
dose settings (fig. 2). In the Historic Group similar anticoagulation and draping 3 
methods were employed, but the radiographic protocols did not include fusion, and 4 
they were not standardized, recorded or consistent between cases. 5 
 6 
Procedure 7 
All patients underwent repair with Zenith Fenestrated devices (Cook Medical, IN, 8 
USA). Major differences in operative techniques between cohorts did exist: before 9 
device deployment, some target-vessels were pre-marked with catheters in the 10 
Modern cohort, and an axillo-bi-femoral bypass was performed in the Historic 11 
cohort. In Modern cases, an initial digital-subtraction angiogram (DSA) was omitted. 12 
The 3D overlay image was used selectively to guide catheterization of the target 13 
vessels, and the use of selective DSA and hand-injections was kept to an absolute 14 
minimum. Contrast (Visipaque 320) for hand-injections was diluted to 50% strength. 15 
The power injector was not used until the completion angiogram. There was no 16 
systematic approach to radiation reduction in the Historic cohort.   17 
 18 
Procedural Data, Outcomes and Statistics 19 
Radiation exposure was reported as air kerma at the interventional reference point 20 
of 15 cm towards the tube from the radiological isocentre (Gy) and dose-area 21 
product [DAP] (Gy.cm2). Contrast volumes were recorded for all patients in the 22 
Modern Group, but not for the Historic Group. Therefore, the total number of 23 
angiograms was obtained for each case as a surrogate marker to provide a 24 
 8 
descriptive comparator, although the differences in technique does not make this a 1 
reliable method of comparison.  Rapidity of cannulation was not available and thus 2 
was not an outcome measure. 3 
 4 
Recorded secondary outcome measures included 30-day mortality, permanent 5 
spinal cord injury and non-surgical complications. Peri-operative renal function was 6 
recorded as estimated glomerular filtration rate (eGFR) on pre-procedure, post-7 
operative day 1, and on the day of discharge.   8 
 9 
Data analysis was performed using SPSS statistics version 22.0 (IBM corporation, 10 
Chicago, Ill) and reported as per guidelines.16 Procedural data were not-normally 11 
distributed and non-parametric tests were used: results expressed as median and 12 
inter-quartile range. Differences in the distribution of continuous variables between 13 
the Modern Group and Historic group were tested using the Mann-Whitney U test. 14 
The Kruskal-Wallis test was used to identify any difference in renal function across 15 
the three different time-points for each group. Categorical variables were analyzed 16 
using the Fisher exact test. P values less than 0.05 were considered significant.   17 
 18 
RESULTS 19 
A total of 42 patients who underwent FEVAR were reviewed in this study, 21 in each 20 
cohort. Demographic data are given in Table 1Table 2. Fusion of pre-operative CTA 21 
with the bony volume acquired during rotational CBCT was successful at first 22 
attempt in 19 of the 21 cases in the Fusion Imaging Group, the remaining two cases, 23 
 9 
the CBCT was not possible due to technical failure attributed to the learning curve of 1 
performing CBCT. 2 
 3 
Procedural Data and Radiation Dose Outcomes 4 
Median procedure time for the Modern Group was 285 mins (inter-quartile range; 5 
268-322) versus 450 mins (IQR; 360-540) for the Historic Group (p=<0.001) (fig.3). In 6 
terms of radiation parameters, median air kerma was 1.59 Gy (IQR; 1.09-2.11) for 7 
the Modern Group and 4.4 Gy (IQR; 3.2-7) for the Historic Group (p=<0.001), whilst 8 
median dose-area product for the Modern group was 158 Gy.cm2 (IQR; 123-226) 9 
compared to 264 Gy.cm2 (IQR; 173.3-366.8) for the Historic Group (p=0.006) (fig.4).  10 
Breakdowns based on CBCT and the remainder of the procedure are included in 11 
Table 4, and depicted in a per-patient illustration in Figure 5. Significantly fewer 12 
angiograms were used in the Modern Group (10.5, IQR; 7-14.5) compared with the 13 
Historic Group (24, IQR; 21.5-32.5) (p=<0.001). There was no significant difference in 14 
fluoroscopy time (p=0.372). Median length of stay for the Modern group was 5 days 15 
(IQR; 4-7.5) compared with 9 days (7-17) for the Historic group (p=0.001). The 16 
imaging quality did not differ (fig.2). 17 
  18 
Secondary outcomes 19 
There were no aneurysm-related deaths within 30 days of the procedure in either 20 
group. There were no differences in eGFR across the three time-points for either the 21 
Modern Group or the Historic group: pre-op 67 (IQR; 44-90), day 1 post-op 60 (47-22 
86.5), discharge 66 (38-87) (p=0.91), and pre-op 68 (49.2-84.7), day 1 post-op 67 23 
(43.5-85), discharge 71 (52.5-84) (p=0.87), respectively.  Renal complications 24 
 10 
described in Table 5. There was no permanent spinal cord ischaemia in either group. 1 
In the Historic group, 2 patients required laparotomies on the same admission: in the 2 
first instance for small bowel obstruction, and in the second case for infected 3 
haematoma. The former patient had a prolonged stay on the intensive care unit and 4 
received haemofiltration, also suffered a posterior circulation cerebral infarct and 5 
severe chest sepsis. One patient in the Historic group suffered a cardiac arrest, 6 
however was revived successfully. There were no conversions to open repair. The 7 
frequency of complications is given in table 3. 8 
Technical Success 9 
In the Modern group, a total of 63 vessels were catheterized. One patient sustained 10 
a left renal artery dissection that was recognized intra-operatively and treated with a 11 
self-expanding stent (Zilver, Cook Medical, IN, USA).  There were nine type II 12 
endoleaks identified on the final angiogram in the Modern group. In the Historic 13 
group, one renal artery was partially covered by a misaligned fenestration, 14 
preventing branch stent deployment, however was found to be patent on 15 
completion angiogram. A further attempt was made six weeks later to catheterize 16 
this target but was abandoned. Another patient sustained a left external iliac artery 17 
dissection requiring patch angioplasty of the common femoral artery and re-lining of 18 
the external iliac with a self-expanding stent (Zilver, Cook Medical, IN, USA). Four 19 
type II endoleaks were observed intra-operatively.   20 
 21 
DISCUSSION 22 
The results of this study demonstrate that introduction of advanced imaging 23 
techniques like fusion and a team based approach is technically feasible, and may 24 
 11 
provide an element of radiation safety awareness that improves the overall safety of 1 
complex aortic procedures. We observed significant reductions in radiation 2 
parameters, procedure-time and estimated blood loss in the Modern group, 3 
compared with the Historic cohort.  We also reflect an ongoing dedication to refining 4 
our technique by decreasing our pulse rate through the Modern cohort. Other 5 
immediate and short term benefits are more likely attributable to a change in the 6 
approach to the Aortic practice at our centre.  7 
 8 
A first report comparing fusion assistance to standard fluoroscopic imaging in 9 
complex aortic endografting was published in 2011.17 An Artis Zeego (Siemens 10 
Healthcare, Erlangen, Germany) and an 8sDR protocol, consisting of 397 frames 11 
taken at 60 f/s, in the majority of cases (80%). Although there was a significant 12 
difference in the radiation output using CBCT, the overall amount of radiation 13 
emitted did not differ from the historic control, which led the authors to postulate 14 
that this technique may aid in dose reduction. A different technique was adopted by 15 
Hertault et al to fuse pre-operative CTA with intra-operative imaging and were able 16 
to effect a significant reduction in radiation dose compared with historic controls, 17 
and report the lowest radiation output across a range of contemporary studies (table 18 
1).6  By contrast, McNally et al document higher radiation doses in their study, but 19 
again emphasize its utility.5 The finding in this study that fluoroscopy time is not 20 
significantly reduced despite reductions in radiation dose is in keeping with two of 21 
the studies described above,5, ,1517 and suggests that radiation dose can be affected 22 
by radiation settings more than simply “time on the pedal”. Furthermore, radiation 23 
output differed significantly across studies using the same fusion imaging system 24 
 12 
(Siemens Zeego) implies that reductions in radiation are multifactorial and not 1 
dependent on fusion alone.  2 
 3 
Given the complexity of modern imaging systems and hybrid rooms, close 4 
collaboration between specialist radiographers and vascular surgeons is crucial to 5 
ensure optimal outcomes.18 For our new approach, radiographers received two-day 6 
training sessions and were closely supported by a surgeon with extensive prior 7 
experience with the Artis Zeego system. Radiographers worked closely with the 8 
surgeon to ensure tight collimation, filtering and the use of low-dose radiation 9 
settings. 10 
 11 
A major limitation to current fusion techniques used by most moderns systems is 12 
that CBCT exposes the patient to considerable radiation.19 Carrell et al7 have 13 
developed a registration system that utilizes pre-operative CTA to create a series of 14 
digitally reconstructed radiographs (DRR) at progressive degrees of virtual C-arm 15 
rotation, precluding the need for CBCT.  The system used by Hertault and colleagues 16 
in their paper of the same conclusion (Discovery IGS 730), GE, Chalfont, UK) was able 17 
to reliably fuse pre-operative CTA with intra-operative fluoroscopy using orthogonal 18 
antero-posterior and lateral single acquisitions only.6 There is clearly scope for 19 
further development of novel registration techniques. 20 
 21 
Although this study is an accurate clinical audit of our change in practice, there are 22 
some issues that may limit its generalizability.  We acknowledge that comparing new 23 
practice with historic controls is a weak study design and introduces bias: there is a 24 
 13 
different in style and technique between different practitioners that will bias the 1 
results. We recognize that these weaknesses may introduce bias into the 2 
conclusions, but we also feel that the significant change in radiation dose is worthy 3 
of report. The use of retrospective data is always a challenge: recording of contrast 4 
volumes was not routine in the historic cohort, making a valuable comparison 5 
between the two study groups impossible for this important outcome variable. Total 6 
number of angiograms was collected as a surrogate marker, although we 7 
acknowledge that this data is not as robust as contrast volume, since contrast type 8 
and concentrations are not accounted for in such a comparison.  The concept of the 9 
‘Aortic Team’ did vary across the two cohorts and there was more standardization of 10 
operators in the modern experience. This makes a strict comparison of imaging 11 
modalities difficult, since it was not possible to control for variation in operative 12 
strategy and imaging protocols in the historic group.  Most specifically, the lack of 13 
consistency in frame rate in the historic cohort compared with the modern cohort 14 
could alone contribute to a large portion of radiation dose reduction. We feel that 15 
the significant reductions in radiation dose strongly supports the practice of using a 16 
standardized and integrated approach to these procedures. 17 
 18 
CONCLUSION 19 
 20 
The introduction of fusion imaging by a team of surgeons and radiographers is 21 
feasible, and may contribute to an overall improved awareness of radiation safety 22 
practices that lead to significant reduction in radiation overall.   23 
24 
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Table 1: Studies to-date of fusion-assisted complex aortic complex aortic endografting. 2 
Study n Procedure Imaging 
System 
DAP (Gy.cm2) Air Kerma 
(Gy) 
Dijkstra, 2011 8 (5sDR) FEVAR Siemens 
Zeego 
- 
 
7 (4-12) 
 
Hertault, 
2014 
18 (2D 
fusion) 
FEVAR GE Inspiron 43.7 (24.7-
57.5) 
 
McNally, 
2014 
12 
19 
FEVAR-2 fen 
FEVAR-3,4 fen 
Siemens 
Zeego 
- 
- 
1.38 (+/- 
0.52) 
2.7  (+/- 1.4) 
Sailer, 2014 31 FEVAR/BEVAR Phillips 
Allura Xper  
143 (120-166) - 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
Table 2: Demographics, co-morbidities and aneurysm morphology. COPD- Chronic obstructive pulmonary 1 
disease, IHD- Ischaemic heart disease, CRF- Chronic renal failure, ESRF- End stage renal failure, CCF- Congestive 2 
cardiac failure 3 
 Modern group Historic Group P value 
Total 21 21  
 
Demographics 
   
Male:Female 17:4 18:3 - 
Age [mean (SD)] 72.9 (8.02) yrs 74 (7.4) yrs 0.64 
Height [mean (SD)] 171 (6.5) cm 170 (8.2) cm 0.72 
Weight [mean (SD)] 82 (10.8) kg 79 (10.3) kg 0.38 
BMI 27.9 (IQR 25.5-
30.5) 
27.6 (IQR 24.2-30.3) 0.56 
 
Comorbidities 
   
Hypertension 19 (90%) 18 (85%) 1 
Dyslipidaemia 19 (90%) 20 (95%) 1 
Smoking (current) 6 (28%) 8 (38%) 0.74 
COPD 7 (33%) 12 (57%) 0.21 
IHD 9 (42%) 15 (71%) 0.11 
Diabetes Mellitus 4 (19%) 4 (19%) 1 
CRF 6 (28%) 5 (23%) 1 
ESRF 0 (0%) 0 (0%) - 
CCF 3 (14%) 3 (14%) 1 
Arrhythmia 1 (.04%) 2 (.09%) 1 
 
Aneurysm Morphology 
   
Sac Size [median 
(IQR)] 
6.2 cm (5.8-7.7) 6.5 cm (5.8-7.9) 0.9 
Juxtarenal 17 (81%) 20 (95%) - 
Thoracoabdominal 4 (19%) 1 (5%) - 
 
Number of 
Fenestrations (not 
including scallops) 
   
4x 5 5 - 
3x 12 11 - 
2x 3 4 - 
1x 1 1 - 
 4 
 5 
 6 
 7 
 20 
 1 
 2 
Table 3: Rate of complications 3 
Complication Modern group Historic Group P value 
Cardiac 0 (0%) 3 (14%) 0.23 
Pulmonary 0 (0%) 4 (19%) 0.1 
Renal 4 (19%) 3 (14%) 1 
Bleeding 0 (0%) 2 (9%) 0.48 
Gastrointestinal 0 (0%) 2 (9%) 0.48 
Stroke 0 (0%) 1 (5%) 1 
 4 
 5 
Table 4: Median Dose and DAP for the CBCT and Procedure 6 
 CBCT Fluoroscopy Acquisition 
(DSA) 
Total 
Median 
Radiation Dose 
(Gy) 
0.13 1.07 0.50 1.59 
Median DAP 
(Gy.cm2) 
36.9 86.7 44.9 159 
**Spin doses calculated using a local conversion for kV and mGy. Assuming uncollimated beam and 0 7 
mm Cu.  Fl doses calculated using a local conversion for DAP. Assuming a mix of PA and lateral at ~100 kV and 8 
0.9 mm Cu.  Acq doses calculated using a local conversion for DAP. Assuming a mix of PA and lateral at ~85 kV 9 
and 0 to 0.1 mm Cu. 10 
 11 
 12 
Table 5: Renal Complications, online only 13 
Historic Group 
Post-op AKI, treated with IV hydration 
Right renal artery fenestration misaligned, acute deterioration in renal function, 
but responded to aggressive hydration 
Acute occlusion of right renal stent with deterioration in renal function, managed 
conservatively 
Modern Group 
Background of CKD II. Post-op AKI creat 223, managed medically, no 
haemofiltration 
Post-op AKI, resolved with hydration 
Background CKD stage III with known bilateral hydronephrosis in inflammatory 
aneurysm. Treated bilateral JJ stents, Creat 298 at peak 
LRA dissection, treated intraop with additional Zilver Stent, but still poor flow. On 
follow up, EGFR 39 and creat 157 with atrophy of left kidney 
14 
 21 
 1 
